Source label information, not individualized medical advice. This record applies to the product and labeler shown below. Compare the exact formulation, strength and country with your package and the current source label.
Generic nameSELENIUM SULFIDE
Labeler / manufacturerPadagis Israel Pharmaceuticals Ltd
RouteTOPICAL
Drug classDrug class not supplied in source label
Product NDC45802-040
Label effective date2025-05-31
Official product label reference
Selenium Sulfide — Padagis Israel Pharmaceuticals Ltd
This page contains 17 source sections for SELENIUM SULFIDE, topical route. Label set 28b84e3c-ae44-40bb-93c4-2625e19f7e61, version 8.
Label records can cover multiple strengths or package sizes. A label listing does not by itself establish FDA approval or current market availability. Check the source and application history for this specific product.
Uses described in the label
INDICATIONS AND USAGE For the treatment of tinea versicolor, seborrheic dermatitis of the scalp, and dandruff.
Dosage and administration — label text
DOSAGE AND ADMINISTRATION See application instructions on rear panel of this bottle. For treatment of dandruff and seborrheic dermatitis: For the usual case, two applications each week for two weeks will afford control. After this, the suspension may be used at less frequent intervals - weekly, every two weeks, or even every 3 or 4 weeks in some cases. The preparation should not be applied more frequently than required to maintain control. For treatment of tinea versicolor: Apply to affected areas and lather with a small amount of water. Allow product to remain on skin for 10 minutes, then rinse the body thoroughly. Repeat this procedure once a day for seven days.
Contraindications
CONTRAINDICATIONS This product should not be used by patients allergic to any of its components.
Warnings and precautions
WARNINGS AND PRECAUTIONS: For External Use Only . Do not use on broken skin or inflamed areas. If allergic reactions occur, discontinue use. Avoid getting shampoo in eyes or in contact with genital area as it may cause irritation and burning. KEEP THIS AND ALL MEDICATIONS OUT OF REACH OF CHILDREN.
Adverse reactions
ADVERSE REACTIONS In decreasing order of severity: skin irritation, occasional reports of increase in amount of normal hair loss, discoloration of hair (can be avoided or minimized by thorough rinsing of hair after treatment). As with other shampoos, oiliness or dryness of hair and scalp may occur.
Unclassified section
For External Use Only Shake Well Before Use Rx Only
APPLICATION INSTRUCTIONS Keep tightly capped. SHAKE WELL BEFORE USING . Product may damage jewelry; remove jewelry before use. For treatment of dandruff and seborrheic dermatitis of the scalp: 1. Massage about 1 or 2 teaspoonsful of suspension into wet scalp. 2. Allow to remain on scalp for 2 to 3 minutes. 3. Rinse scalp thoroughly. 4. Repeat application and rinse thoroughly. 5. After treatment, wash hands well. 6. Repeat treatments as directed by physician. For treatment of tinea versicolor: 1. Apply to affected areas and lather with a small amount of water. 2. Allow to remain on skin for 10 minutes. 3. Rinse body thoroughly. 4. Repeat this procedure once a day for seven days.
CONTAINS: Selenium sulfide 2.5%; bentonite, citric acid, cocoamphocarboxyglycinate, ethylene glycol monostearate, fragrance, glycerol monoricinoleate, lauramide DEA, sodium lauryl sulfate, sodium phosphate (monobasic), titanium dioxide, and water.
Manufactured by Padagis, Minneapolis, MN 55427 www.padagis.com Rev 05-25 27G26 RC F2/27G26 RC B2
Product description
DESCRIPTION A liquid antiseborrheic, antifungal preparation for topical application. Selenium sulfide has the molecular formula SeS 2 and has a molecular weight of 143.09.
Clinical pharmacology
CLINICAL PHARMACOLOGY Selenium sulfide appears to have a cytostatic effect on cells of the epidermis and follicular epithelium, thus reducing corneocyte production.
Precautions
PRECAUTIONS General - Should not be used when acute inflammation or exudation is present as increased absorption may occur. Information for Patients - Application to skin or scalp may produce skin irritation or sensitization. If sensitivity reactions occur, use should be discontinued. May be irritating to mucous membranes of the eyes and contact with this area should be avoided. When applied to the body for treatment of tinea versicolor, Selenium Sulfide Topical Suspension USP, 2.5% (Lotion) may produce skin irritation especially in the genital area and where skin folds occur. These areas should be thoroughly rinsed after application. Carcinogenesis - Studies in mice using dermal application of 25% and 50% solutions of 2.5% selenium sulfide topical suspension, over an 88 week period, indicated no carcinogenic effects. Pregnancy - WHEN USED ON BODY SURFACES FOR THE TREATMENT OF TINEA VERSICOLOR, SELENIUM SULFIDE IS CLASSIFIED AS PREGNANCY CATEGORY "C". Animal reproduction studies have not been conducted with Selenium Sulfide Topical Suspension USP, 2.5% (Lotion). It is also not known whether Selenium Sulfide Topical Suspension USP, 2.5% (Lotion) can cause fetal harm when applied to body surfaces of a pregnant woman or can affect reproduction capacity. Under ordinary circumstances Selenium Sulfide Topical Suspension USP, 2.5% (Lotion) should not be used for the treatment of tinea versicolor in pregnant women. Pediatric Use - Safety and effectiveness in infants have not been established.
General precautions
General - Should not be used when acute inflammation or exudation is present as increased absorption may occur.
Information for patients
Information for Patients - Application to skin or scalp may produce skin irritation or sensitization. If sensitivity reactions occur, use should be discontinued. May be irritating to mucous membranes of the eyes and contact with this area should be avoided. When applied to the body for treatment of tinea versicolor, Selenium Sulfide Topical Suspension USP, 2.5% (Lotion) may produce skin irritation especially in the genital area and where skin folds occur. These areas should be thoroughly rinsed after application.
Carcinogenesis and mutagenesis and impairment of fertility
Carcinogenesis - Studies in mice using dermal application of 25% and 50% solutions of 2.5% selenium sulfide topical suspension, over an 88 week period, indicated no carcinogenic effects.
Pregnancy
Pregnancy - WHEN USED ON BODY SURFACES FOR THE TREATMENT OF TINEA VERSICOLOR, SELENIUM SULFIDE IS CLASSIFIED AS PREGNANCY CATEGORY "C". Animal reproduction studies have not been conducted with Selenium Sulfide Topical Suspension USP, 2.5% (Lotion). It is also not known whether Selenium Sulfide Topical Suspension USP, 2.5% (Lotion) can cause fetal harm when applied to body surfaces of a pregnant woman or can affect reproduction capacity. Under ordinary circumstances Selenium Sulfide Topical Suspension USP, 2.5% (Lotion) should not be used for the treatment of tinea versicolor in pregnant women.
Children and adolescents
Pediatric Use - Safety and effectiveness in infants have not been established.
Overdose information
OVERDOSAGE Accidental Oral Ingestion- Selenium Sulfide Topical Suspension USP, 2.5% (Lotion) is intended for external use only. There have been no documented reports of serious toxicity in humans resulting from acute ingestion of Selenium Sulfide Topical Suspension USP, 2.5% (Lotion); however, acute toxicity studies in animals suggest that ingestion of large amounts could result in potential human toxicity. For this reason, evacuation of the stomach contents should be considered in cases of acute oral ingestion.
Supply and packaging
HOW SUPPLIED Selenium Sulfide Topical Suspension USP, 2.5% (Lotion) is available as follows: 4 fl oz plastic bottle (NDC 45802- 040 -64).
Storage and handling
Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature].
The text is extracted from a US structured product label. Tables are represented as text where supplied; formatting and illustrations may be lost. A missing section does not mean a risk is absent. This reference has not been independently reviewed by a clinician and is not a live safety-alert service.